Filing Details
- Accession Number:
- 0001209191-15-015509
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-18 17:49:03
- Reporting Period:
- 2015-02-17
- Filing Date:
- 2015-02-18
- Accepted Time:
- 2015-02-18 17:49:03
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 879169 | Incyte Corp | INCY | Services-Commercial Physical & Biological Research (8731) | 943136539 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1454983 | S Richard Levy | 1801 Augustine Cut-Off Wilmington DE 19803 | Evp, Chief Drug Dev&Medical Of | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2015-02-17 | 3,683 | $17.79 | 21,888 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2015-02-17 | 8,317 | $14.72 | 30,205 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2015-02-17 | 12,000 | $76.90 | 18,205 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2015-02-17 | 3,683 | $0.00 | 3,683 | $17.79 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2015-02-17 | 8,317 | $0.00 | 8,317 | $14.72 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 90,217 | 2019-01-18 | No | 4 | M | Direct | |
| 0 | 2018-01-24 | No | 4 | M | Direct |
Footnotes
- Represents weighted average sale price. Actual sale prices ranged from $75.55 - $78.00.
- Reporting person undertakes to provide upon request by Securites and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
- Beginning January 19, 2012, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
- Beginning January 25, 2011, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
Billionaire Hedge Funds
